banner
Peptide (cRGD)-modified cationic liposomes
Inquiry

Cat. No.: X26-05-ZQ2825

Peptide (cRGD)-modified cationic liposomes

Synonym: cRGD peptide-modified cationic LPs; cRGD-modified cationic liposomes; cRGD-functionalized cationic liposomal nanocarriers

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
This advanced engineered system features cyclic arginylglycylaspartic acid peptide functionalized cationic liposomes. The structural matrix utilizes a high-purity lipid bilayer vesicle core formulated with specific cationic lipids to establish a robust positive surface potential, whose exterior boundary is surface-modified with specific cyclic arginylglycylaspartic acid (cRGD) targeting peptides linked via covalent polymer-lipid anchors. This precise modification coordinates a highly uniform charged surface landscape with a dense target-mimetic ligand array, altering overall membrane bending elasticity and surface hydration parameters to completely prevent physical vesicle aggregation while leaving the internal aqueous reservoir empty.
Source
Custom synthesis
Functional Group
cRGD cyclic peptide; Cationic lipid matrix
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.